BLA Filing definition

BLA Filing means the acceptance by the FDA of the filing of a BLA for the applicable Product in the U.S.
BLA Filing means the complete submission and acceptance by the applicable Regulatory Authority of a BLA for filing; provided that such Regulatory Authority has not issued a refusal to file letter or a letter identifying deficiencies for which the Regulatory Authority will suspend its review following submission of such filing.
BLA Filing means the filing of a BLA for the Product in the US.

Examples of BLA Filing in a sentence

  • As soon as practicable after the BLA Filing Date, and consistent with the transition plan adopted by the PDC and contained in the initial Clinical Development Plan, the Company shall transition such clinical and other studies ongoing with respect to the Products which have been identified in such Clinical Development Plan as being transferred to ERS in such transition plan from the Company's sole control to the control of the Party(ies) set forth in the initial Clinical Development Plan.

  • Therefore, until the Initial Regulatory Filing is made (the "BLA Filing Date"), the Company shall be primarily responsible for conducting the clinical studies and all other regulatory matters, manufacturing matters and/or pre-clinical studies necessary to support, prepare and file the Initial Regulatory Filing until the BLA Filing Date, and the Company shall use all commercially reasonable efforts necessary to make the Initial Regulatory Filing.

  • Ray further argues that Lynass’s declaration about their relationship does not “offer any proof that Lynass relied on Ray for ‘moral, financial, or personal support and guidance.’” Id. The undersigned agrees.

  • In addition, prior to the first BLA Filing, the Roche Alliance Director shall be available upon Eleven’s request to answer questions about the status of the Roche Group’s development activities once per each Calendar Quarter (except for such Calendar Quarter that Roche provides Eleven with the annual summary report).

  • The expenses charged by either Party to its R&D Account in accordance with Section 5.3.2 shall not, subject to Section 7.1.4, be an amount in excess of [***] the amount included for such expenses in the then current Annual Research Budget, Annual Development Budget or Post BLA Filing Annual Budget, as appropriate, unless the JSC recommends and each Party approves such excess expenses.


More Definitions of BLA Filing

BLA Filing means the date on which the first BLA for Product in any country of the Territory has been submitted which BLA has been accepted (but not yet approved) by the applicable Regulatory Authority.
BLA Filing means a Biologics Licensing Application or New Drug Application filed as a result of activities under this Agreement with the FDA, or the equivalent application to the equivalent agency in any other country, the filing of which is necessary to market and sell a Target Product, including all amendments and supplements to any of the foregoing.
BLA Filing means a Biologic License Application, or other application for the approval of marketing of any LICENSED PRODUCT, which is submitted to the FDA in a MAJOR MARKET.
BLA Filing means the Biologics License Application with respect to Teplizumab that was submitted by PRVB to the FDA.
BLA Filing means a Biologics License Application (“BLA”) with respect to RP1 that was submitted by Borrower to the FDA.
BLA Filing means (i) the filing of a BLA for the Product in the Field in the U.S. or (ii) the acceptance of the equivalent application by the equivalent agency in any other regulatory jurisdiction, the filing of which is necessary to obtain Product Approval for the Product in the Field in such jurisdiction, including acceptance of an MAA by the EMEA (or acceptance by the applicable Regulatory Authority in a given country in Europe to the extent mutual recognition or other national approval procedure is utilized) and acceptance of a *** by the ***.
BLA Filing means a Biologics License Application (“BLA”) with respect to RP1 that was submitted by Borrower to